Clinical Trial Update: Efficacy and Safety of 30% Salicylic Acid and 10% Nicotinamide Combined Therapy in Melasma [NA]

View source ↗

Summary

A completed clinical trial assessed the efficacy and safety of a combined topical therapy consisting of 30% salicylic acid and 10% nicotinamide for melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Nicotinamide (nicotinamide)
• Salicylic acid (salicylic acid)

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Melasma | NA | Status: COMPLETED